meso- tri(N- methyl- pyridyl)mono(N- dodecyl- pyridyl)porphine

a photosensitizing agent used in photodynamic therapy to treat malaria; structure in first source

Also Known As:

5-(4-N-dodecylpyridyl)-10,15,20-tri(4-N-methylpyridyl)-21H,23H-porphyrin; 5-(4-N-dodecylpyridyl)-10,15,20-tri(4-N-methylpyridyl)-21H,23H-porphyrin tetraiodide; C12 porphyrin tetraiodide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Jori, Giulio: 2 articles (07/2015 - 09/2012)
2.	Acherar, Samir: 1 article (07/2015)
3.	Frochot, Céline: 1 article (07/2015)
4.	Le Guern, Florent: 1 article (07/2015)
5.	Meledje, Esme: 1 article (07/2015)
6.	Stallivieri, Aurélie: 1 article (07/2015)
7.	Vanderesse, Régis: 1 article (07/2015)
8.	Coppellotti, Olimpia: 1 article (09/2012)
9.	Dabiré, Roch K: 1 article (09/2012)
10.	Di Martino, Piera: 1 article (09/2012)

Related Diseases

Malaria

09/01/2012 - "In order to validate the approach for the control of the malaria vector, we tested the photo-larvicidal activity of a novel porphyrin, namely meso-tri(N-methyl-pyridyl), mono(N-dodecyl-pyridyl)porphine, C12, associated with two specifically selected carriers, against Anopheles gambiae s.s. "
07/01/2015 - "Synthesis and photophysical properties of the photoactivatable cationic porphyrin 5-(4-N-dodecylpyridyl)-10,15,20-tri(4-N-methylpyridyl)-21H,23H-porphyrin tetraiodide for anti-malaria PDT."

Related Drugs and Biologics

1.	Porphyrins
2.	1-phenyl-3,3-dimethyltriazene (PDT)